Skip to main content

Polarityte, Inc.

PTEDelisted Jul 10, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001076682

Polarityte, Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jan 30, 2023; 46 institutions reported holding it in 13F filings for Q1 2022, worth $4.01M in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Polarityte, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of PTE: Q3 2021 compared with Q4 2021
MeasureQ3 2021Of which not filed for Q4 2021Q4 2021Change
Holders49141−7
Shares10.8M27.7K9.94M−809.7K (−7.5%)
Value$6.92M$18.0K$5.83M−$1.07M (−15.5%)

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (10)

Institutions that held Polarityte, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to PTE in Q4 2021
InstitutionSharesValue% of portfolio
Difesa Capital Management, LP666,170$391.0K0.28%
Levin Capital Strategies, L.P.150,000$88.0K0.01%
HighTower Advisors, LLC60,070$35.0K0.00%
Two Sigma Advisers, LP15,600$9.00K0.00%
Jane Street Group, LLC13,048$8.00K0.00%
PFG Advisors12,820$8.00K0.00%
Onyx Bridge Wealth Group LLC12,000$8.00K0.00%
FMR LLC500$00.00%
Simplex Trading, LLC344$00.00%
CoreCap Advisors, LLC1––

Sold out (17)

Institutions that held Polarityte, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Not filed for Q4 2021 yet (1)

Institutions that held Polarityte, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PTE in Q3 2021 that haven't filed for Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
HighPoint Advisor Group LLC27,705$18.0K